With 30% annual returns for a decade, I’m buying this for my Stocks & Shares ISA

Oliver Rodzianko has been looking for a new investment for his Stocks and Shares ISA. Here’s one he’s decided is worth his cash.

| More on:
Investor looking at stock graph on a tablet with their finger hovering over the Buy button

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I believe that a Stocks and Shares ISA is one of the best tools I can have in my arsenal. Over my lifetime, it can save me hundreds of thousands of pounds when I come to sell my investments if I’ve held them long enough.

All of my investments are in an ISA, and here’s what I think is a new no-brainer buy for me. I’ve decided it’s going to be my latest addition.

Please note that tax treatment depends on the individual circumstances of each client and may be subject to change in future. The content in this article is provided for information purposes only. It is not intended to be, neither does it constitute, any form of tax advice. Readers are responsible for carrying out their own due diligence and for obtaining professional advice before making any investment decisions.

Making money while I sleep

ResMed (NYSE:RMD) is the company I’ve found. My analysis of it sees great growth and profitability but with a moderate risk in its valuation.

The company helps people in more than 140 countries sleep healthily if they’re dealing with sleep apnoea.

Its operations can be broken down in to sleep and respiratory care that’s 88% of revenue and software that’s 12% of revenue.

Comparing the stock to its US benchmark, the S&P 500, we can see how I expect to make substantial money in my sleep from this one while also doing good in the world.

On average, ResMed has grown in price by 30% per year since 2014. The S&P 500 has gained just 17% annually on average over the same time frame.

Here’s what sold me

The company has excellent margins, with a net margin in the top 13% of businesses in its industry. Also, its revenues have been growing at a strong 12%, and its earnings have been growing at 15% a year on average over the last three years.

Also, I like the fact that the business is diversified across Europe, Asia, and other markets. That means I’m protected if there’s an economic downturn that primarily hits the US.

The company does have quite a lot of debt for its industry, but the balance sheet looks healthy enough overall for me. It has more equity than liabilities, which is a good sign, I feel.

Source: TradingView

Understanding the value

Considering the shares are down over 40% from their all-time high right now, it’s tempting for me to think I’m getting a good deal. However, it’s not that simple.

The shares have a price-to-earnings ratio of around 25 right now. That’s quite high considering the price has dropped so significantly recently.

What this means is that while the investment might be ‘on sale’, it’s still selling at a risky premium to what’s normal in its industry. But I’m not surprised by that, considering its stellar results.

The risks are worth it to me

Also, I’ve seen evidence that the company could be getting less efficient. Its assets are growing at a faster rate than its revenues, and this means the firm isn’t managing to get the same value out of its investments as it was in the past. That can be an indicator of a slower-growth future to come.

However, I love the shares, and I think the pros outweigh the cons. Even at such a high price, I believe the firm has a strong future ahead of it and is managed well. So, I’ll be a shareholder this month.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Oliver Rodzianko has no position in any of the shares mentioned. The Motley Fool UK has recommended ResMed. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young Black man sat in front of laptop while wearing headphones
Investing Articles

Investing just £10 a day in UK stocks could bag me a passive income stream of £267 a week!

This Fool explains how investing in UK stocks rather than buying a couple of takeaway coffees a day could help…

Read more »

Investing Articles

A cheap stock to consider buying as the FTSE 100 hits all-time highs

Roland Head explains why the FTSE 100 probably isn’t expensive and highlights a cheap dividend share to consider buying today.

Read more »

Investing Articles

If I were retiring tomorrow, I’d snap up these 3 passive income stocks!

Our writer was recently asked which passive income stocks she’d be happy to buy if she were to retire tomorrow.…

Read more »

Investing Articles

As the FTSE 100 hits an all-time high, are the days of cheap shares coming to an end?

The signs suggest that confidence and optimism are finally getting the FTSE 100 back on track, as the index hits…

Read more »

Investing Articles

Which FTSE 100 stocks could benefit after the UK’s premier index reaches all-time highs?

As the FTSE 100 hit all-time highs yesterday, our writer details which stocks could be primed to climb upwards.

Read more »

Investing Articles

Down massively in 2024 so far, is there worse to come for Tesla stock?

Tesla stock has been been stuck in reverse gear. Will the latest earnings announcement see the share price continue to…

Read more »

Young Caucasian woman with pink her studying from her laptop screen
Dividend Shares

These 2 dividend stocks are getting way too cheap

Jon Smith looks at different financial metrics to prove that some dividend stocks are undervalued at the moment and could…

Read more »

Investing Articles

Is the JD Sports share price set to explode?

Christopher Ruane considers why the JD Sports share price has done little over the past five years, even though sales…

Read more »